Targeting the phosphoinositide 3-kinase isoform p110δ impairs growth and survival in neuroblastoma cells

Clinical Cancer Research

Volumn 14, Issue 4, 2008, Pages 1172-1181

  Boller, Danielle ^a   Schramm, Alexander ^b   Doepfner, Kathrin T ^a   Shalaby, Tarek ^a   Von Bueren, André O ^a   Eggert, Angelika ^b   Grotzer, Michael A ^a   Arcaro, Alexandre ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE 3 KINASE P110DELTA; PROTEIN BCL 2; PROTEIN KINASE B; S6 KINASE; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADRENAL GLAND; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CATALYSIS; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; ISOENZYMES; NEUROBLASTOMA; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 39749195528     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0737     Document Type: Article

References (42)